Your browser doesn't support javascript.
loading
Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.
Chyra, Zuzana; Sevcikova, Tereza; Vojta, Petr; Puterova, Janka; Brozova, Lucie; Growkova, Katerina; Filipova, Jana; Zatopkova, Martina; Grosicki, Sebastian; Barchnicka, Agnieszka; Jedrzejczak, Wieslaw Wiktor; Waszczuk-Gajda, Anna; Jungova, Alexandra; Mikulasova, Aneta; Hajduch, Marian; Mokrejs, Martin; Pour, Ludek; Stork, Martin; Harvanova, Lubica; Mistrik, Martin; Mikala, Gabor; Robak, Pawel; Czyz, Anna; Debski, Jakub; Usnarska-Zubkiewicz, Lidia; Jurczyszyn, Artur; Stejskal, Lukas; Morgan, Gareth; Kryukov, Fedor; Budinska, Eva; Simicek, Michal; Jelinek, Tomas; Hrdinka, Matous; Hajek, Roman.
Afiliação
  • Chyra Z; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Sevcikova T; Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Vojta P; Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
  • Puterova J; Brno University of Technology, Centre of Excellence IT4Innovations, Brno, Czech Republic.
  • Brozova L; Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Growkova K; Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Filipova J; Department of Biology and Ecology, Faculty of Science, University of Ostrava, Czech Republic.
  • Zatopkova M; Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Grosicki S; Dept. of Hematology and Cancer Prevention, Medical University of Silesia in Katowice, Poland.
  • Barchnicka A; Dept. of Hematology and Cancer Prevention, Medical University of Silesia in Katowice, Poland.
  • Jedrzejczak WW; Department of Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland.
  • Waszczuk-Gajda A; Department of Haematology, Oncology and Internal Diseases, Medical University of Warsaw, Poland.
  • Jungova A; Charles University Hospital Pilsen, Czech Republic.
  • Mikulasova A; Biosciences Institute, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Hajduch M; Institute of Molecular and Translational Medicine, Palacky University, Olomouc, Czech Republic.
  • Mokrejs M; IT4Innovations, VSB, Technical University of Ostrava, Ostrava, Czech Republic.
  • Pour L; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Czech Republic.
  • Stork M; Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Czech Republic.
  • Harvanova L; Department of Haematology and Transfusiology, University Hospital Bratislava, Slovakia.
  • Mistrik M; Department of Haematology and Transfusiology, University Hospital Bratislava, Slovakia.
  • Mikala G; Dept. of Haematology and Stem Cell Transplantation, South Pest Central Hospital, Budapest, Hungary.
  • Robak P; Department of Haematology, Medical University of Lodz, Copernicus Memorial Hospital, Lódz, Poland.
  • Czyz A; Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland.
  • Debski J; Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland.
  • Usnarska-Zubkiewicz L; Dept. and Clinic of Haematology, Blood Neoplasms, Wroclaw Medical University, Poland.
  • Jurczyszyn A; Jagiellonian University Medical College, Cracow, Poland.
  • Stejskal L; Silesian Hospital Opava, Opava, Czech Republic.
  • Morgan G; Dpt. of Medicine, Multiple Myeloma Research Perlmutter Cancer Center, NYU School of Medicine, USA.
  • Kryukov F; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Budinska E; RECETOX, Faculty of Science, Masaryk university in Brno, Brno, Czech Republic.
  • Simicek M; Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Jelinek T; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
  • Hrdinka M; Dpt. of Clinical studies, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
  • Hajek R; Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
Haematologica ; 106(2): 601-604, 2021 02 01.
Article em En | MEDLINE | ID: mdl-32381580
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose Tipo de estudo: Diagnostic_studies Limite: Humans Idioma: En Revista: Haematologica Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos